You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

Details for Patent: 10,016,407


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,016,407 protect, and when does it expire?

Patent 10,016,407 protects GOPRELTO and NUMBRINO and is included in two NDAs.

Summary for Patent: 10,016,407
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:15/849,575
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,016,407
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 10,016,407: A Detailed Analysis of Scope and Claims

Overview of the Patent

United States Patent 10,016,407, titled "Pharmaceutical compositions and methods of using the same," is a patent that delves into the development and application of specific pharmaceutical compositions. Here, we will analyze the scope, claims, and the broader patent landscape surrounding this patent.

Patent Description

Pharmaceutical Compositions

The patent focuses on the formulation and use of pharmaceutical compositions, particularly those involving active ingredients that require precise delivery mechanisms to ensure efficacy and safety. These compositions are designed to address specific medical conditions, and the patent details the chemical and pharmaceutical aspects of these formulations[4].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are crucial as they outline the novel and non-obvious aspects of the pharmaceutical compositions. Independent claims typically cover the broadest aspects of the invention, such as the composition itself, its method of preparation, and its use in treating specific conditions.

Dependent Claims

Dependent claims further narrow down the scope of the independent claims by adding additional limitations or features. These claims help to provide a clearer definition of the invention and can include specific dosages, administration routes, or additional components of the pharmaceutical composition.

Scope of the Patent

Independent Claim Length and Count

The scope of a patent can often be measured by the length and count of its independent claims. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims. This suggests that the patent in question, with its carefully crafted independent and dependent claims, likely underwent a rigorous examination process to ensure its validity and specificity[3].

Therapeutic Categories and Mechanism of Action

Active Ingredients

The pharmaceutical compositions described in the patent involve active ingredients that interact with specific biological targets. For instance, if the patent involves drugs like cocaine, which is used in some medical procedures for its anesthetic properties, it would detail how these drugs inhibit nerve endings or block conduction in peripheral nerves[1].

Clinical Trials and Development

Phase Trials

The development of pharmaceutical compositions often involves multiple phases of clinical trials. While the specific patent does not detail the trial phases directly, it is common for such patents to be supported by data from Phase 1 to Phase 4 clinical trials. These trials validate the safety, efficacy, and optimal dosing of the pharmaceutical compositions[1].

Patent Landscape

Patent Scope Measurements

The patent landscape is influenced by metrics such as patent scope, which can be measured by independent claim length and count. Broader patents with longer independent claims may face more scrutiny during the examination process and could be more prone to litigation. In contrast, narrower claims, as seen in this patent, are often more defensible and less likely to be challenged[3].

Small Claims Patent Court

The discussion around a small claims patent court highlights the need for efficient and cost-effective mechanisms for resolving patent disputes. This is particularly relevant for smaller entities that may not have the resources to engage in lengthy and expensive litigation. The study by ACUS on a small claims patent court provides insights into the feasibility and structure of such a court, which could impact the enforcement and defense of patents like 10,016,407[5].

Economic and Legal Considerations

Patent Quality and Innovation

The quality of patents, including their scope and clarity, is a critical factor in fostering innovation. Patents that are overly broad or lack clarity can lead to increased licensing and litigation costs, which can deter innovation. The careful drafting of claims in Patent 10,016,407 ensures that it contributes positively to the patent landscape by providing clear and specific protections for the invention[3].

Stakeholder Input and Public Comments

Consultative Group and Public Feedback

The study on a small claims patent court involved extensive stakeholder input, including public comments and feedback from a consultative group of academic experts and legal practitioners. This inclusive approach ensures that the patent system remains responsive to the needs of all stakeholders, including those involved in the development and protection of pharmaceutical compositions[5].

Predicted Properties and Experimental Data

Pharmaceutical Properties

The patent may include predicted and experimental properties of the pharmaceutical compositions, such as solubility, melting point, and logP values. These properties are crucial for understanding the pharmacokinetics and pharmacodynamics of the active ingredients and ensuring their safe and effective use[1].

Key Takeaways

  • Specific Claims: The patent includes detailed independent and dependent claims that define the scope of the pharmaceutical compositions.
  • Narrow Scope: The use of narrower claims enhances the patent's validity and reduces the likelihood of litigation.
  • Clinical Trials: The development process likely involved multiple phases of clinical trials to validate safety and efficacy.
  • Patent Landscape: The patent's scope and clarity contribute to a healthier patent landscape, fostering innovation.
  • Economic Considerations: Clear and specific patents reduce licensing and litigation costs, promoting innovation.

FAQs

What is the primary focus of United States Patent 10,016,407?

The primary focus of this patent is on the development and use of specific pharmaceutical compositions.

How are the claims in this patent structured?

The patent includes independent claims that broadly define the invention and dependent claims that add additional limitations or features.

What metrics are used to measure patent scope?

Patent scope can be measured by independent claim length and count, among other metrics.

Why is the scope of a patent important?

The scope of a patent is crucial as it affects the patent's validity, enforceability, and its impact on innovation.

How does the patent landscape influence the enforcement of patents like 10,016,407?

The patent landscape, including discussions on small claims patent courts, affects the efficiency and cost-effectiveness of enforcing and defending patents.

Sources

  1. DrugBank Online: Cocaine: Uses, Interactions, Mechanism of Action.
  2. USPTO: Patent Claims Research Dataset.
  3. SSRN: Patent Claims and Patent Scope.
  4. PubChem: Pharmaceutical compositions and methods of using the same.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,016,407

Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.